> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bayer Submits Updated Essure Postmarket Report
- URL: https://www.fdaweb.com/bayer-submits-updated-essure-postmarket-report/
- Published: 2018-04-25T12:00:00.000Z
- Updated: 2026-09-15T00:00:47.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5141301

Bayer has submitted to FDA a heavily redacted updated 12-month interim postmarket surveillance [report](https://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHFOIAElectronicReadingRoom/UCM605587.pdf?ref=fdaweb.com) on the company’s Essure 522 study. The company says the report was updated with the subject accrual completion date, the Bayer regulatory contact information, and one new paragraph at the end of Section 3.4.2.